Altered O
anterior O
cingulate O
cortex O
to O
hippocampus O
effective O
connectivity O
in O
response O
to O
drug O
cues O
in O
men O
with O
cocaine O
use O
disorder O
Drug-related O
attentional O
bias O
may O
have O
significant O
implications O
for O
the O
treatment O
of O
cocaine O
use O
disorder O
( O
CocUD O
) O
. O

However O
, O
the O
neurobiology O
of O
attentional O
bias O
is O
not O
completely O
understood O
. O

This O
study O
employed O
dynamic O
causal O
modeling O
( O
DCM O
) O
to O
conduct O
an O
analysis O
of O
effective O
( O
directional O
) O
connectivity O
involved O
in O
drug-related O
attentional O
bias O
in O
treatment-seeking O
CocUD O
subjects O
. O

The O
DCM O
analysis O
was O
conducted O
based O
on O
functional O
magnetic O
resonance O
imaging O
( O
fMRI O
) O
data O
acquired O
from O
fifteen O
CocUD O
subjects O
while O
performing O
a O
cocaine-word O
Stroop O
task O
, O
during O
which O
blocks O
of O
Cocaine O
Words O
( O
CW O
) O
and O
Neutral O
Words O
( O
NW O
) O
alternated O
. O

There O
was O
no O
significant O
attentional O
bias O
at O
group O
level O
. O

Although O
no O
significant O
brain O
activation O
was O
found O
, O
the O
DCM O
analysis O
found O
that O
, O
relative O
to O
the O
NW O
, O
the O
CW O
caused O
a O
significant O
increase O
in O
the O
strength O
of O
the O
right O
( O
R O
) O
anterior O
cingulate O
cortex O
( O
ACC O
) O
to O
R O
hippocampus O
effective O
connectivity O
. O

Greater O
increase O
of O
this O
connectivity O
was O
associated O
with O
greater O
CW O
reaction O
time O
( O
relative O
to O
NW O
reaction O
time O
) O
. O

The O
increased O
strength O
of O
R O
ACC O
to O
R O
hippocampus O
connectivity O
may O
reflect O
ACC O
activation O
of O
hippocampal O
memories O
related O
to O
drug O
use O
, O
which O
was O
triggered O
by O
the O
drug O
cues O
. O

This O
circuit O
could O
be O
a O
potential O
target O
for O
therapeutics O
in O
CocUD O
patients O
. O

No O
significant O
change O
was O
found O
in O
the O
other O
modeled O
connectivities O
. O

2 O
. O

METHODS O
2.1 O
Subjects O
The O
study O
was O
officially O
approved O
by O
the O
local O
Institutional O
Review O
Board O
, O
and O
was O
performed O
in O
accordance O
with O
the O
Code O
of O
Ethics O
of O
the O
World O
Medical O
Association O
( O
Declaration O
of O
Helsinki O
) O
. O

Informed O
consent O
was O
obtained O
from O
each O
subject O
. O

The O
CocUD O
subjects O
were O
from O
a O
treatment O
study O
, O
in O
which O
the O
majority O
of O
the O
participants O
were O
male O
. O

All O
MRI O
scans O
took O
place O
prior O
to O
the O
initiation O
of O
medication O
treatment O
. O

All O
subjects O
were O
screened O
using O
the O
Structured O
Clinical O
Interview O
for O
DSM-IV O
( O
SCID O
) O
and O
underwent O
physical O
examination O
and O
medical O
history O
. O

The O
Addiction O
Severity O
Index O
was O
obtained O
to O
document O
lifetime O
drug O
and O
alcohol O
use O
. O

Female O
subjects O
were O
screened O
with O
a O
urine O
pregnancy O
test O
immediately O
prior O
to O
MRI O
scanning O
. O

Each O
subject O
’ O
s O
urine O
was O
screened O
for O
tetrahydrocannabinol O
( O
THC O
) O
, O
opiates O
, O
cocaine O
, O
amphetamines O
, O
and O
benzodiazepines O
( O
Syva O
Company O
, O
Deerfield O
, O
IL O
) O
, O
and O
each O
subject O
was O
screened O
for O
alcohol O
with O
an O
Intoximeter O
Alco-Sensor O
III O
breathalyzer O
( O
Intoximeters O
, O
Inc. O
, O
St. O
Louis O
, O
MO O
) O
immediately O
prior O
to O
MRI O
scanning O
. O

Subject O
inclusion O
criteria O
were O
: O
( O
1 O
) O
18–55 O
years O
old O
; O
( O
2 O
) O
right-handed O
; O
( O
3 O
) O
free O
of O
alcohol O
at O
the O
time O
of O
MRI O
scanning O
; O
( O
4 O
) O
met O
Diagnostic O
and O
Statistical O
Manual O
Fourth O
Edition O
( O
DSM-IV O
) O
criteria O
for O
current O
cocaine O
dependence O
based O
on O
the O
Structured O
Clinical O
Interview O
for O
DSM-IV O
. O

Exclusion O
criteria O
were O
: O
( O
1 O
) O
subjects O
who O
met O
current O
or O
past O
DSM-IV O
Axis O
I O
disorder O
other O
than O
substance O
abuse O
or O
substance O
dependence O
; O
( O
2 O
) O
medical O
disorders O
or O
taking O
medication O
that O
may O
affect O
the O
central O
nervous O
system O
; O
( O
3 O
) O
claustrophobia O
experienced O
during O
MRI O
or O
MRI O
simulator O
sessions O
; O
( O
4 O
) O
any O
definite O
or O
suspected O
clinically O
significant O
abnormalities O
of O
the O
brain O
on O
Fluid O
Attenuated O
Inversion O
Recovery O
( O
FLAIR O
) O
MRI O
scans O
; O
( O
5 O
) O
positive O
pregnancy O
test O
result O
. O

Based O
on O
above O
criteria O
, O
fifteen O
CocUD O
subjects O
, O
among O
the O
26 O
CocUD O
subjects O
who O
were O
scanned O
, O
were O
included O
for O
final O
analysis O
. O

See O
Table O
1 O
for O
the O
demographics O
and O
drug-use O
information O
of O
these O
subjects O
. O

This O
is O
a O
free-standing O
study O
; O
all O
the O
CocUD O
subjects O
( O
n=26 O
) O
who O
were O
scanned O
were O
considered O
. O

Eleven O
CocUD O
subjects O
were O
excuded O
because O
of O
either O
missing O
behavioral O
performance O
data O
( O
n=1 O
) O
; O
excessive O
head O
motion O
during O
the O
fMRI O
scan O
( O
n=2 O
) O
; O
clinically O
significant O
abnormal O
results O
on O
FLAIR O
scan O
of O
the O
brain O
( O
n=4 O
) O
; O
subject O
’ O
s O
request O
to O
terminate O
the O
scanning O
( O
n=2 O
) O
; O
or O
current O
alcohol O
dependence O
( O
n=2 O
) O
. O

The O
majority O
of O
the O
participants O
were O
male O
. O

The O
one O
female O
subject O
who O
was O
scanned O
was O
excluded O
because O
of O
excessive O
head O
motion O
. O

2.2 O
Cocaine-word O
Stroop O
fMRI O
Task O
The O
subject O
was O
presented O
with O
ten O
cocaine O
words O
( O
CW O
) O
and O
ten O
neutral O
words O
( O
NW O
) O
, O
one O
word O
at O
a O
time O
. O

The O
CW O
and O
NW O
were O
matched O
in O
letter O
length O
. O

Both O
CW O
( O
e.g. O
, O
“ O
cocaine O
” O
, O
“ O
crack O
” O
) O
and O
NW O
( O
e.g. O
, O
“ O
kitchen O
” O
, O
“ O
table O
” O
) O
were O
frequently O
used O
words O
in O
the O
English O
language O
. O

Each O
word O
when O
presented O
was O
randomly O
printed O
in O
one O
of O
three O
different O
colors O
( O
blue O
, O
green O
, O
or O
red O
) O
. O

The O
subject O
was O
instructed O
to O
ignore O
the O
meaning O
of O
the O
word O
and O
to O
press O
the O
appropriate O
button O
to O
denote O
the O
color O
in O
which O
the O
word O
was O
printed O
. O

Each O
word O
was O
shown O
for O
a O
maximum O
duration O
of O
1800 O
ms O
( O
if O
no O
response O
) O
, O
but O
the O
display O
of O
the O
word O
was O
terminated O
by O
a O
response O
, O
after O
which O
a O
blank O
screen O
was O
shown O
for O
the O
remainder O
of O
the O
trial O
up O
to O
1900 O
ms O
. O

The O
next O
trial O
immediately O
began O
with O
the O
presentation O
of O
the O
next O
word O
. O

Four O
CW O
blocks O
and O
four O
NW O
blocks O
alternated O
with O
a O
12 O
s O
pause O
between O
blocks O
. O

Within O
each O
block O
( O
58 O
s O
per O
block O
) O
, O
thirty O
words O
were O
presented O
. O

The O
effect O
of O
drug O
cues O
on O
the O
reaction O
times O
( O
ΔRT O
) O
was O
measured O
by O
the O
mean O
reaction O
time O
during O
all O
the O
CW O
blocks O
minus O
that O
during O
all O
of O
the O
NW O
blocks O
, O
i.e. O
, O
ΔRT O
= O
RT O
( O
CW O
) O
minus O
RT O
( O
NW O
) O
. O

Only O
the O
correct-response O
trials O
were O
included O
when O
calculating O
the O
mean O
reaction O
times O
. O

ΔRT O
was O
treated O
as O
a O
measure O
of O
attentional O
bias O
at O
the O
behavioral O
level O
in O
the O
present O
study O
. O

2.3 O
fMRI O
Data O
Acquisition O
MRI O
data O
were O
acquired O
on O
a O
Philips O
3.0 O
T O
Intera O
system O
with O
an O
eight O
channel O
receive O
head O
coil O
( O
Philips O
Medical O
Systems O
, O
Best O
, O
Netherlands O
) O
. O

Single O
shot O
spin O
echo O
echoplanar O
imaging O
( O
EPI O
) O
was O
used O
for O
acquiring O
fMRI O
data O
. O

The O
fMRI O
acquisition O
parameters O
were O
: O
SENSE O
acceleration O
factor O
2.0 O
, O
repetition O
time O
2500 O
ms O
, O
echo O
time O
75 O
ms O
, O
flip O
angle O
90 O
degrees O
, O
field O
of O
view O
240 O
mm O
× O
240 O
mm O
, O
in-plane O
resolution O
3.75 O
mm O
× O
3.75 O
mm O
, O
25 O
axial O
slices O
, O
slice O
thickness O
3.75 O
mm O
, O
interslice O
gap O
1.25 O
mm O
, O
224 O
repetitions O
per O
run O
after O
10 O
dummy O
acquisitions O
, O
total O
duration O
per O
run O
was O
10 O
min O
40 O
s. O
2.4 O
fMRI O
Preprocessing O
During O
an O
fMRI O
run O
, O
individual O
scans O
in O
which O
the O
fMRI O
signal O
exceeded O
plus O
or O
minus O
four O
standard O
deviations O
from O
the O
mean O
were O
considered O
to O
be O
outliers O
and O
were O
replaced O
by O
the O
mean O
of O
the O
two O
nearest O
neighbors O
using O
the O
Analysis O
of O
Functional O
NeuroImages O
( O
AFNI O
) O
software O
command O
“ O
3dDespike O
” O
( O
http O
: O
//afni.nimh.nih.gov/afni/ O
) O
. O

All O
subsequent O
preprocessing O
used O
Statistical O
Parametric O
Mapping O
12 O
( O
SPM12 O
) O
software O
( O
http O
: O
//www.fil.ion.ucl.ac.uk/spm/ O
) O
implemented O
in O
Matlab O
R2007b O
( O
Mathworks O
Inc. O
Sherborn O
MA O
, O
USA O
) O
. O

After O
slice O
timing O
correction O
, O
the O
fMRI O
series O
was O
realigned O
to O
the O
first O
image O
to O
correct O
for O
head O
motion O
. O

Runs O
with O
head O
motion O
greater O
than O
1 O
voxel O
( O
3.75 O
mm O
translation O
on O
any O
axis O
) O
or O
rotation O
greater O
than O
3.75 O
degrees O
were O
removed O
from O
the O
analysis O
. O

The O
anatomical O
image O
was O
coregistered O
to O
the O
fMRI O
images O
and O
spatially O
transformed O
to O
Montreal O
Neurological O
Institute O
( O
MNI O
) O
standard O
atlas O
coordinates O
using O
the O
SPM12 O
Normalise O
module O
with O
the O
SPM12 O
T1 O
MNI O
template O
image O
. O

The O
transformation O
parameters O
were O
applied O
to O
the O
fMRI O
images O
, O
which O
were O
resliced O
to O
2 O
mm O
isotropic O
resolution O
and O
spatially O
smoothed O
with O
a O
Gaussian O
filter O
of O
8 O
mm O
isotropic O
full O
width O
at O
half O
maximum O
. O

2.5 O
SPM O
univariate O
analysis O
First O
level O
univariate O
statistical O
analysis O
of O
the O
fMRI O
data O
was O
conducted O
using O
SPM12 O
. O

CW O
and O
NW O
blocks O
( O
conditions O
) O
were O
modeled O
by O
boxcar O
functions O
convolved O
with O
the O
SPM12 O
canonical O
hemodynamic O
response O
function O
. O

The O
parameters O
for O
each O
condition O
were O
estimated O
using O
the O
General O
Linear O
Model O
at O
each O
voxel O
without O
global O
normalization O
. O

The O
fMRI O
time O
series O
was O
high-pass O
filtered O
with O
an O
optimized O
cut-off O
period O
of O
188 O
s O
determined O
by O
the O
Fourier O
transformation O
of O
each O
condition O
’ O
s O
time O
model O
. O

Attentional O
bias O
activation O
was O
defined O
as O
the O
contrast O
at O
each O
voxel O
of O
the O
parameter O
estimate O
for O
CW O
blocks O
minus O
the O
parameter O
estimate O
for O
NW O
blocks O
( O
CW O
minus O
NW O
contrast O
) O
. O

The O
resulting O
set O
of O
voxel O
values O
for O
this O
contrast O
constitutes O
a O
statistical O
parametric O
map O
for O
that O
contrast O
. O

The O
CW O
minus O
NW O
contrast O
image O
( O
one O
per O
subject O
) O
was O
then O
entered O
at O
the O
SPM12 O
second O
level O
( O
i.e. O
, O
random O
effects O
) O
group O
analysis O
. O

To O
determine O
the O
group O
level O
blood-oxygen-level O
dependent O
( O
BOLD O
) O
activation O
, O
a O
SPM12 O
second O
level O
Random O
Effects O
one-sample O
t-test O
was O
conducted O
voxel-wise O
throughout O
the O
whole O
brain O
for O
the O
contrast O
image O
( O
CW O
minus O
NW O
) O
. O

Statistical O
significance O
was O
defined O
as O
family-wise O
error O
( O
FWE O
) O
corrected O
cluster O
probability O
( O
p O
) O
less O
than O
0.05 O
( O
two O
tail O
) O
. O

The O
brain O
activations O
found O
by O
this O
analysis O
were O
used O
for O
DCM O
nodes O
( O
regions O
of O
interest O
) O
selection O
, O
but O
the O
statistical O
significance O
was O
defined O
as O
uncorrected O
cluster O
p O
less O
than O
0.05 O
( O
two O
tail O
) O
. O

It O
is O
commonly O
accepted O
to O
use O
uncorrected O
cluster O
p O
less O
than O
0.05 O
( O
two O
tail O
) O
for O
determining O
DCM O
nodes O
. O

For O
all O
SPM12 O
second O
level O
analyses O
, O
the O
cluster-defining O
threshold O
was O
t O
= O
2.4 O
. O

Anatomical O
labels O
for O
regions O
of O
activation O
were O
determined O
using O
the O
Anatomical O
Automatic O
Labeling O
( O
AAL O
) O
toolbox O
. O

2.6 O
Dynamic O
causal O
modeling O
FMRI-based O
DCM O
is O
a O
biophysical O
model O
of O
the O
underlying O
neuronal O
connectivity O
and O
of O
how O
the O
neuronal O
connectivity O
generates O
the O
observed O
BOLD O
signal O
. O

DCM O
with O
stochastic O
option O
, O
as O
implemented O
in O
SPM12 O
( O
Revision O
6906 O
) O
, O
was O
used O
for O
effective O
connectivity O
analysis O
. O

DCM O
has O
been O
described O
elsewhere O
. O

In O
brief O
, O
the O
mathematical O
model O
of O
the O
underlying O
neuronal O
connectivity O
among O
an O
a O
priori O
selected O
set O
of O
brain O
regions O
is O
a O
system O
of O
bilinear O
differential O
state O
equations O
with O
coefficients O
specified O
by O
three O
matrices O
( O
A O
matrix O
, O
B O
matrix O
and O
C O
matrix O
) O
. O

In O
this O
model O
, O
the O
experimental O
conditions O
( O
i.e. O
, O
CW O
and O
NW O
) O
can O
serve O
as O
inputs O
to O
the O
model O
as O
either O
driving O
inputs O
, O
or O
modulatory O
inputs O
, O
or O
both O
. O

The O
DCM O
analysis O
determines O
which O
particular O
nodes O
in O
the O
model O
exhibit O
effective O
connectivity O
with O
other O
specific O
nodes O
in O
the O
model O
, O
which O
nodes O
receive O
driving O
inputs O
from O
experimental O
conditions O
into O
the O
model O
, O
and O
which O
specific O
connectivities O
between O
nodes O
in O
the O
model O
are O
modulated O
( O
i.e. O
, O
changed O
in O
connectivity O
strength O
, O
in O
units O
of O
Hz O
) O
under O
experimental O
conditions O
. O

A O
node O
( O
driving O
input O
location O
) O
in O
the O
model O
that O
receives O
driving O
inputs O
, O
as O
quantified O
by O
the O
C O
matrix O
parameters O
, O
is O
the O
brain O
region O
among O
the O
nodes O
in O
the O
model O
which O
first O
experiences O
a O
change O
in O
neuronal O
activity O
. O

The O
node O
that O
receives O
the O
driving O
input O
then O
influences O
( O
“ O
drives O
” O
) O
the O
connectivity O
to O
other O
nodes O
in O
the O
model O
. O

The O
endogenous O
( O
or O
fixed O
) O
connectivity O
in O
DCM O
is O
quantified O
by O
the O
A O
matrix O
parameters O
, O
which O
measure O
the O
effective O
connectivity O
strengths O
( O
in O
units O
of O
Hz O
) O
between O
nodes O
, O
regardless O
of O
the O
moment-to-moment O
switching O
on O
and O
off O
of O
inputs O
. O

Experimental O
conditions O
( O
CW O
and O
NW O
) O
can O
modulate O
the O
endogenous O
connectivity O
among O
nodes O
. O

These O
modulation O
effects O
are O
quantified O
by O
the O
B O
matrix O
parameters O
as O
increased O
or O
decreased O
connectivity O
strength O
compared O
to O
the O
endogenous O
connectivity O
at O
different O
times O
in O
the O
experiment O
that O
are O
related O
to O
the O
timing O
of O
changes O
in O
the O
particular O
experimental O
conditions O
. O

2.6.1 O
DCM O
nodes O
DCM O
node O
selection O
criteria O
were O
: O
( O
1 O
) O
the O
brain O
activations O
found O
in O
this O
study O
, O
( O
2 O
) O
previous O
fMRI O
studies O
using O
cocaine O
stimulus O
Stroop O
tasks O
( O
e.g. O
, O
) O
, O
and O
( O
3 O
) O
theories O
about O
attentional O
bias O
( O
e.g. O
, O
) O
. O

Based O
on O
meeting O
the O
combined O
presence O
of O
all O
of O
the O
above O
three O
criteria O
, O
the O
following O
five O
regions O
served O
as O
nodes O
for O
the O
DCM O
analysis O
: O
( O
1 O
) O
left O
( O
L O
) O
anterior O
cingulate O
cortex O
( O
ACC O
) O
( O
x= O
−8 O
, O
y=46 O
, O
z= O
−4 O
) O
; O
( O
2 O
) O
R O
ACC O
( O
x=10 O
, O
y=26 O
, O
z=24 O
) O
; O
( O
3 O
) O
right O
( O
R O
) O
insula O
( O
x=42 O
, O
y= O
−10 O
, O
z= O
−6 O
) O
; O
( O
4 O
) O
R O
hippocampus O
( O
x=36 O
, O
y= O
−18 O
, O
z= O
−14 O
) O
; O
and O
( O
5 O
) O
L O
caudate O
( O
x= O
−18 O
, O
y= O
−8 O
, O
z=22 O
) O
. O

The O
x O
, O
y O
, O
z O
values O
are O
the O
MNI O
coordinates O
of O
the O
center O
of O
each O
node O
, O
which O
were O
defined O
as O
a O
sphere O
with O
5 O
mm O
radius O
and O
centered O
at O
local O
maximum O
of O
the O
regional O
fMRI O
activation O
corresponding O
to O
that O
node O
. O

For O
each O
node O
, O
the O
functional O
activation O
BOLD O
time-series O
, O
which O
was O
used O
for O
DCM O
analysis O
, O
was O
extracted O
using O
the O
methods O
described O
in O
. O

2.6.2 O
Driving O
input O
and O
modulatory O
input O
The O
CW O
and O
NW O
experimental O
conditions O
were O
not O
directly O
used O
as O
inputs O
. O

Following O
and O
, O
we O
created O
a O
parametric O
regressor O
for O
“ O
All O
Words O
” O
contrast O
, O
and O
another O
parametric O
regressor O
for O
CW O
minus O
NW O
contrast O
. O

The O
method O
of O
constructing O
these O
regressors O
can O
be O
found O
online O
( O
https O
: O
//github.com/HaukeHillebrandt/SPM_connectome O
) O
. O

The O
“ O
All O
Words O
” O
contrast O
, O
which O
reflects O
the O
common O
features O
of O
the O
CW O
and O
NW O
, O
was O
used O
as O
a O
single O
input O
to O
the O
DCM O
( O
driving O
input O
) O
. O

The O
CW O
minus O
NW O
contrast O
, O
which O
reflects O
the O
special O
effect O
of O
CW O
over O
NW O
, O
was O
used O
as O
a O
putative O
modulator O
( O
modulatory O
input O
) O
of O
effective O
connectivity O
( O
the O
factor O
causing O
changes O
in O
the O
effective O
connectivities O
) O
. O

In O
the O
present O
study O
, O
the O
changes O
of O
effective O
connectivities O
( O
relative O
to O
the O
endogenous O
connectivities O
) O
caused O
by O
the O
CW O
minus O
NW O
modulator O
are O
termed O
as O
modulatory O
changes O
. O

By O
definition O
, O
a O
modulatory O
change O
reflects O
the O
change O
in O
an O
effective O
connectivity O
caused O
by O
the O
CW O
minus O
the O
change O
in O
this O
effective O
connectivity O
caused O
by O
the O
NW O
. O

Thus O
the O
effects O
of O
drug O
cues O
( O
CW O
) O
on O
the O
behavioral O
performance O
( O
reaction O
time O
) O
, O
brain O
activation O
, O
and O
effective O
connectivity O
were O
all O
assessed O
relative O
to O
NW O
in O
the O
present O
study O
. O

2.6.3 O
DCM O
inference O
Given O
the O
nodes O
of O
the O
model O
, O
a O
DCM O
post-hoc O
optimization O
analysis O
was O
used O
for O
model O
structure O
inference O
. O

Starting O
from O
a O
fully-connected O
model O
, O
the O
post O
hoc O
optimization O
analysis O
systematically O
searches O
for O
an O
optimal O
“ O
sparse O
” O
model O
that O
determines O
which O
particular O
nodes O
exhibit O
effective O
connectivity O
with O
other O
nodes O
( O
i.e. O
, O
endogenous O
connectivity O
) O
, O
which O
nodes O
first O
experience O
a O
change O
in O
neuronal O
activity O
associated O
with O
the O
“ O
All O
Words O
” O
input O
( O
i.e. O
, O
driving O
input O
effects O
) O
, O
and O
which O
effective O
connectivities O
showed O
modulatory O
changes O
associated O
with O
the O
CW O
minus O
NW O
modulator O
. O

Based O
on O
the O
results O
of O
the O
post O
hoc O
optimization O
analysis O
, O
a O
Bayesian O
model O
averaging O
( O
BMA O
) O
analysis O
was O
conducted O
for O
DCM O
parameter O
inference O
, O
with O
a O
model O
space O
consisting O
of O
the O
fully-connected O
model O
and O
the O
optimal O
sparse O
model O
. O

BMA O
averages O
each O
DCM O
parameter O
across O
models O
( O
and O
across O
subjects O
) O
such O
that O
the O
contribution O
of O
each O
model O
( O
of O
each O
subject O
) O
for O
that O
parameter O
was O
weighted O
by O
the O
model O
’ O
s O
posterior O
probability O
. O

